According to the First Information Report (FIR), Delhi Police Crime Branch Inspector Pradeep Kumar Singh and his associate Rajkumar allegedly demanded a bribe of ₹3 crore from the principal accused in the fake medicine case, N Raja, also known as Valliappan. Investigators stated that ₹1.5 crore was to be paid in advance as part of the alleged arrangement.
The CBI investigation revealed that Raja transferred ₹1 crore to Singh in Delhi through hawala channels and subsequently began arranging the remaining amount. Singh allegedly passed on ₹50 lakh to an individual identified as Prabhat. During a subsequent raid conducted by the agency, Singh and Rajkumar were arrested while allegedly in possession of ₹24.70 lakh in cash.
Investigators further alleged that Raja was assured that favourable outcomes in the ongoing cases could be secured through the influence of certain CBI officers and senior government officials. The alleged conspiracy extended beyond the exchange of money and involved promises of manipulating the course of the investigation.
According to the CBI, a meeting was organized on May 14 at Aerocity in Delhi involving Raja, Rajkumar, a senior government official, and several others. During the meeting, the official allegedly assured the participants that the desired outcome in the case could be achieved.
On June 9, the CBI produced Singh and Rajkumar before the Rouse Avenue Court and sought seven days of police custody. The agency informed the court that custodial interrogation was necessary to identify other government officials allegedly involved in the bribery network, trace the movement of the bribe money, and examine digital evidence connected to the case.
The court, however, granted only one day of police custody.
During the hearing, counsel representing Inspector Singh argued that his client had been falsely implicated and denied allegations that he had demanded any bribe.
The Puducherry fake medicine scam is regarded as one of the largest pharmaceutical fraud cases in the country. Investigative agencies have alleged that counterfeit medicines were manufactured and distributed on a massive scale through an extensive network operating across multiple channels.
With the arrest of the Delhi Police officer and his associate, the CBI has widened its investigation to determine the full extent of the alleged corruption network. The agency is now focusing on identifying all individuals involved in the bribery scheme, tracing the financial trail, and uncovering attempts to influence the investigation into one of India's most significant pharmaceutical fraud cases.
About The Author
.jpg)
Comment List